Twinbeech Capital LP Catalent, Inc. Transaction History

Twinbeech Capital LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $2.9 Million - $4.2 Million	90,262 New	90,262 $4.06 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $3.16 Million - $6.67 Million	99,194 New	99,194 $4.3 Million
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $2.7 Million - $5.28 Million	-65,204 Reduced 26.35%	182,242 $8.2 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $17.2 Million - $27 Million	238,286 Added 2601.38%	247,446 $17.9 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $798,752 - $1.04 Million	9,160 New	9,160 $983,000
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $4.08 Million - $5.39 Million	-43,290 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $4.54 Million - $5.28 Million	37,960 Added 712.2%	43,290 $5.54 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $581,876 - $758,725	5,330 New	5,330 $709,000
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $2.21 Million - $2.71 Million	-25,693 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $1.87 Million - $2.38 Million	25,693 New	25,693 $2.2 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.